PUBLICATION: San Antonio Business Journal San Antonio-based Bluegrass Vascular Technologies is making some significant headway outside the U.S. The biotech firm has moved closer to securing a CE Mark, regulatory approval that would allow Bluegrass Vascular to commercialize its initial medical device, the Surfacer Inside-Out Access Catheter System, in Europe. READ MORE
PUBLICATION: San Antonio Business Journal Bluegrass Vascular Technologies Inc. has taken a critical step toward commercialization of its initial medical device — the Surfacer Inside-Out Access Catheter System. Gabriele Niederauer, president and CEO of the private medical technology company, which is based in San Antonio and focused on vascular access technologies, said a European medical […]
PUBLICATION: Silicon Hills Bluegrass Vascular Technologies – the San Antonio-based startup relocated from Lexington, Kentucky. It raised $4.5 million in Series A financing last year led by the Targeted Technology Fund of San Antonio. The company makes the Surfacer, a central venous access catheter system. Gabriele Niederauer joined the company in September of 2014 as […]
PUBLICATION: San Antonio Express News Serial entrepreneurs are those who take on the risks of building a company good enough to be sold to an older, larger company and taking the proceeds to start another company. An example of such an executive in San Antonio’s health care and medical devices sector is Gabriele Niederauer, now […]
PUBLICATION: San Antonio Business Journal Bluegrass Vascular Technologies is developing a special catheter system that enables physicians to gain venous access to a patient using a novel approach. The company moved from Kentucky to San Antonio last year after closing on $4.5 million in funding and then hired Dr. Gabriele Niederauer, a seasoned senior medical […]
PUBLICATION: San Antonio Business Journal Bluegrass Vascular Technologies has been quite busy of late by closing on a new round of funding and hiring a new chief executive to lead the biotech company. In late July, I reported that the Kentucky-based medical technology company had closed on $4.5 million in new investor funding and was […]
PUBLISHED DATE: March 2016
PUBLICATION: Cath Lab Digest: Volume 22 – Issue 3, March 2014
PUBLICATION: Endovascular Today Severe renal dysfunction and venous occlusive disease are major causes of morbidity, mortality, and increased medical costs, especially within the dialysis population. The long-term risks of central venous access include occlusion, which can occur within days of catheter placement and is a common problem in patients requiring repeated access or semipermanent access. Central […]
PUBLICATION: Start-Up Magazine Although central venous catheters are commonly employed to lever long-term dialysis, nutrition and chemotherapy, nearly 10% of patients have an upper extremity venous occlusion that renders the vein impenetrable by standard access techniques. READ MORE
PUBLICATION: BusinessLexington When he was president of the University of Kentucky, Lee Todd strongly encouraged faculty members to take their original ideas to the next step and turn them into new businesses and jobs to better the commonwealth. One company to emerge from the minds of UK personnel was technology incubator Therix Medical. And now, Therix […]